# US 2016/0355871 A1 · Methods and compositions for detecting bacterial contamination

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0355871 A1
- Document ID: US20160355871A1
- Status: Published application
- Kind: A1
- Application number: 14/900,260
- Filed: 2014-07-23
- Published: 2016-12-08
- Earliest claimed: 2013-07-25
- Assignees: Dch Molecular Diagnostics, Inc.
- Inventors: James Jian Quan Want; Xiangmin Cui; HiuNam Chan
- Web page: https://patentgrep.com/patent/US20160355871A1

## CPC

- C12Q 1/689: for bacteria
- C12Q 2525/15: incorporating a consensus or conserved sequence
- C12Q 2531/113: PCR
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Compositions, reactions mixtures, kits, and systems for detecting bacterial contamination are provided, as well as methods of using the same.

## Claims

### Claim 1

A method of detecting bacterial contamination of a platelet sample by any of at least five bacterial genera, comprising:
(a) subjecting the sample or a portion thereof to a nucleic acid amplification reaction under conditions to yield a detectable amount of an amplicon of no more than about 800 bases in a single reaction mixture, said reaction mixture comprising a single primer pair and a single detectable probe, wherein the primer pair flanks the amplicon, the amplicon comprises a conserved sequence to which the detectable probe hybridizes, and the conserved sequence is identical among the at eight-five bacterial genera; and
(b) detecting hybridization to the amplicon by the probe, wherein the hybridization by the probe yields a detectable signal indicative of bacterial contamination of the platelet sample by any of the at least five bacterial genera.

### Claim 2

(canceled)

### Claim 3

(canceled)

### Claim 4

(canceled)

### Claim 5 (depends on 1)

The method of claim 1, wherein the platelet sample is a platelet concentrate isolated by aphaeresis.

### Claim 6 (depends on 5)

The method of claim 5, wherein nucleic acids isolated from less than 5 mL of the platelet concentrate are subjected to the nucleic acid amplification reaction.

### Claim 7

(canceled)

### Claim 8

(canceled)

### Claim 9 (depends on 1)

The method of claim 1, wherein the amplicon is generated from a bacterial 16S rRNA polynucleotide template

### Claim 10 (depends on 1)

The method of claim 1, wherein the detecting of bacterial contamination is completed prior to transfusion into a recipient.

### Claim 11

(canceled)

### Claim 12

(canceled)

### Claim 13

(canceled)

### Claim 14

(canceled)

### Claim 15

(canceled)

### Claim 16 (depends on 1)

The method of claim 1, wherein the bacterial species genera are selected from the group consisting of: Staphylococcus aureus, Staphylococcus aureus Mu3; Staphylococcus epidermidis, Streptococcus agalactiae, Streptococcus pyogenes, Streptococcus pneumonia, Escherichia coli, Citrobacter koseri, Clostridium perfringens, Enterococcus faecalis, Klebsiella pneumonia, Lactobacillus acidophilus, Listeria monocytogenes, Propionibacterium granulosum, Pseudomonas aeruginosa, Serratia marcescens, Bacillus cereus, Staphylococcus aureus Mu50, Yersinia enterocolitica, Staphylococcus simulans, Micrococcus luteus, and Enterobacter aerogenes.

### Claim 17

(canceled)

### Claim 18 (depends on 1)

The method of claim 1, wherein the detectable signal has a linear range of detection across at least 5 logs.

### Claim 19 (depends on 18)

The method of claim 18, further comprising determining the amount of bacterial contamination based on the probe signal.

### Claim 20

(canceled)

### Claim 21

(canceled)

### Claim 22

A composition for amplification and detection of a portion of a 16S rRNA polynucleotide, said portion being less than about 800 nucleotides in length, comprising:
a first primer comprising at least 10 contiguous nucleotides of the sequence as set forth in SEQ ID NO: 9;
a second primer comprising at least 10 contiguous nucleotides of the sequence as set forth in SEQ ID NO: 10; and,
a probe comprising at least 10 contiguous nucleotides of the sequence as set forth in SEQ ID NO: 16, or the complement thereof.

### Claim 23 (depends on 22)

The composition of claim 22, wherein the composition is in a container.

### Claim 24

(canceled)

### Claim 25

(canceled)

### Claim 26

(canceled)

### Claim 27

A reaction mixture for amplification and detection of a portion of a 16S rRNA polynucleotide, said portion being less than about 800 nucleotides in length, comprising
sample nucleic acid;
primers that, in an amplification reaction with a target 16S rRNA polynucleotide, amplify an amplicon of at least 50 nucleotides in length, the amplicon having 90% sequence identity with any of SEQ ID NO: 1-3 when optimally aligned;
a probe that specifically hybridizes to either strand of the amplicon; and
a polymerase;
wherein the reaction mixture is in a reaction site.

### Claim 28

(canceled)

### Claim 29 (depends on 27)

The reaction mixture of claim 27, wherein, in an amplification reaction with a target 16S rRNA polynucleotide, amplification of about 1 pg-5 pg of DNA from any one of a plurality of target species by the primers and probes has a cycle threshold value (CT) of less than 30.

### Claim 30 (depends on 22)

A kit for the detection of bacterial contamination of a platelet sample, said kit comprising the composition of claim 22.

### Claim 31 (depends on 30)

A method of using the kit of claim 30, the method comprising:
performing a nucleic acid amplification reaction on a sample or a portion thereof with a single primer pair to yield a detectable amount of an amplicon of no more than about 800 bases of a 16S rRNA polynucleotide, wherein amplification of about 1 pg-5 pg of DNA from any one of a plurality of bacterial species from different genera has a cycle threshold value (CT) of less than 30; and
detecting the amplicon with one or more detectable probes, wherein each of the one or more detectable probes specifically hybridizes to a conserved sequence, and the conserved sequence is identical among a plurality of bacterial species from different genera.

### Claim at position 32

-47. (canceled)

### Claim 48 (depends on 1)

The method of claim 1, wherein the amplification reaction yields a detectable amount of amplicon of no more than 300 bases.

### Claim 49 (depends on 1)

The method of claim 1, wherein the amplification reaction yields a detectable amount of amplicon of 100-200 bases.

### Claim 50 (depends on 1)

The method of claim 1, wherein the single primer pair comprises a first primer comprising at least 10 contiguous nucleotides of a sequence as set forth in SEQ ID NO: 4, 7, or 9 and a second primer comprising at least 10 nucleotides of a sequence as set forth in SEQ ID NO: 5, 6, 8, or 10.

### Claim 51 (depends on 1)

The method of claim 1, wherein the probe comprises at least 10 contiguous nucleotides of a sequence as set forth in Table 3, or a complement thereof.

### Claim 52 (depends on 1)

The method of claim 1, wherein the nucleic acid amplification reaction contains less than 5 pg of starting nucleic acids from the bacterial contamination.

### Claim 53 (depends on 1)

The method of claim 1, wherein the sample or portion thereof has not been cultured at a temperature above 35° C. prior to amplification.

### Claim 54 (depends on 1)

The method of claim 1, wherein the steps of (a) and (b) are completed within 24 hours after obtaining the sample.
